BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Modular Genetics, Inc. And Monsanto Company (MON) Collaborate To Develop Platform To Optimize Protein Properties


10/19/2005 5:13:00 PM

ST. LOUIS and WOBURN, Mass., March 14 /PRNewswire-FirstCall/ -- Today, Modular Genetics Inc. (MGI) and Monsanto Company announced a collaborative relationship to advance Monsanto's protein optimization platform.

MGI has developed and patented breakthrough protein optimization platforms, which are used for the screening, identification and assembly of proteins for research.

As part of the three-year collaboration, Monsanto will gain an exclusive license to use MGI's platform for use in agricultural applications. Applying this platform, Monsanto will be able to accelerate its ability to identify and develop new traits for platforms like agronomic traits, enhanced nutritional content and improved yield properties.

"The collaboration with MGI is a terrific complement to the industry- leading research-and-development program we've built at Monsanto," said Robert T. Fraley, Executive Vice President and Chief Technology Officer of Monsanto. "Access to MGI's high-capacity protein optimization platform will help us advance projects more quickly and efficiently through our discovery pipeline, ultimately leading to the ability to offer more products to more farmers."

"Modular Genetics is thrilled to have aligned our scientific efforts with such a strong partner as Monsanto," said Kevin A. Jarrell, Co-founder, President and Chief Scientific Officer of MGI. "We've worked hard to develop technology that we believe takes a new approach to protein optimization and we're excited to have the opportunity to build on the work we've done in the pharmaceutical sector and apply our technology in the agricultural arena."

The collaboration includes the establishment of a research facility in Cambridge, Mass., where a team of Monsanto researchers will coordinate Monsanto's protein optimization program. Additionally, MGI will relocate its business and research headquarters to the new Cambridge facility.

Specific financial terms of the agreement were not disclosed.

Modular Genetics Inc. of Woburn, Mass., is a privately held growth-stage biotechnology company developing products via automated gene engineering. See: http://www.modulargenetics.com/ .

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information on Monsanto, see: http://www.monsanto.com/ .

Monsanto Company

CONTACT: Ben Kampelman of Monsanto Company, +1-314-694-6192, or KevinJarrell of Modular Genetics Inc., +1-781-376-0020



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES